Bionano Genomics does not accept resumes submitted by agencies. 2003. 10X Genomics is a life science technology company building products to interrogate, understand, and master biology to advance human health. Competitors Stock Price Forecast The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 12.00, with a high … Find handy financial articles, info-rich videos, webinars by the industry experts and a glossary of terms made easy. Statistics show that Bionano Genomics Inc. has outperformed its competitors in share price, compared to the industry in which it operates. CYDY Stock Insider Trades - Buys and Sells - CytoDyn Inc : a breakdown of the latest and past insider buys and sells in the stock. Cytodyn rumours - dnjs.pinkwhite.de Bionano Genomics Bionano Genomics, Inc. Competitors Stock Price Forecast The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 12.00, with a high … Kochava Media Index - Bionano Genomics, Inc. Competitors ... BioNano Genomics has 77 employees across 3 locations and $8.5 M in annual revenue in FY 2020. Saphyr, a recently discovered tool used by researchers collaborating across the globe, could be useful in predicting which COVID-19 patients might experience lingering symptoms. Gene mapping outfit BioNano Genomics is hoping to set itself apart in the personalized medicine market, where a number of gene sequencing competitors are lining up. CEO Asked about TAM, “So in cytogenetics, broadly speaking, there's roughly 2,500 labs worldwide. We would like to show you a description here but the site won’t allow us. See the full list of Bionano Genomics alternatives and competitive updates on Owler, the world’s largest community-based business insights platform. The four topic winners of the Poster Competition will be announced at the beginning of the Bionano Genomics 2022 Symposium on Monday, January 10th, 2022. BioNano Genomics, Inc.'s Email Format. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Founded way back in 2002, San Diego startup Bionano Genomics has taken in just over $132 millionfrom investors that include pharmaceutical giant Novartis to “provide essential genomic information no other technology can provide.” Their system is called Saphyr, and like the Illumina product offering, it is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Even if the clinical assays that BioNano and their collaborators have genotyped are small numbers of patients, the existence of those assays gives a map for competitors -- metrics to match or beat and data to compare against. Was this due to the action of Reddittraders? Investors typically determine Bionano Genomics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Nanochannel chips, integrated software, both primary and secondary, automated imaging instruments and application specific reagents are some of the other products and services the … The firm engages in the development and marketing of Saphyr system, a … In the past mon BioNano Genomics General Information Description. Illumina's Nova Seq, which does tons of insurance reimbursed runs is not CLIA cleared, nor is PacBio's Sequence, nor is the overwhelming majority of genomics insurance reimbursed tools. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. Create an Alert Quickflows 3.40-0.31 -8.36% NASDAQ ... A key part of performance analysis is seeing how a company stacks up against its competitors. Do MarketBeat users like Bionano Genomics more than its competitors? Global Optical Genome Mapping Market Report 2021, Featuring Key Players OpGen Inc, Bionano Genomics, Inc., Nabsys Inc and Nucleome Informatics Pvt Ltd News provided by Research and Markets Buying Bionano Genomics Stock Is A Gambit. Summary Competitors Valuation Dec 10, 2021. Cytodyn rumours. Although it trades on the NASDAQ, Bionano is effectively a penny stock, with share prices trading at $0.25-$0.50 for most of 2020. Benzinga - Aug 20, 2021, 10:40AM. The revenue growth was below Bionano Genomics Inc 's competitors average revenue growth of 111.98 %, recorded in the same quarter. Yet, BTIG analysts led by Sung Ji Nam anticipate further room for upside as they initiate the coverage of the stock with a buy rating. There are 6 companies in the Bionano Genomics, Inc. corporate family. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. / Sales 2022. Bionano Genomics Inc comparison to it's Competition's in Price to earnings, Price to Sales, Price to Book Ratios - CSIMarket Company Name, Ticker, Competitors, else.. STOCKS They are headquartered at San Diego, CA, United States, and have 1 advertising & marketing contacts listed on Kochava. Bionano Genomics's top competitors include PacBio, Oxford Nanopore and 10x Genomics. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. We provide you with deep insights and analysis, so that your trading performance gets better. Bionano Genomics Inc Add to Watchlists. Bionano Genomics, Inc. Common Stock (BNGO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Bionano Genomics, Inc. has 77 total employees across all of its locations and generates $8.50 million in sales (USD). It is classified as operating in the Scientific Research & Development Services industry. It’s certainly possible that they contributed to the rally. Bionano Genomics Announces 2022 Symposium Featuring Four Consecutive Days of OGM Presentations and Live Panel Discussions Delivered by 25 Different Customers Across a Wide Range of Genetic Disease and Cancer Applications GlobeNewswire Inc. - 12/9/2021 8:00:00 AM: Bionano Genomics Announces Publication of Study Evaluating Optical Genome Mapping for … It developed a platform to analyse biomolecule structural variations and long segments of genomic DNA. BioNano Genomics (BNGO) is a niche life sciences instrumentation company. Bionano Genomics competes with Charles River, Global Cord, Quest Diagnostics, Guardant Health, and Berkeley Lights; as well as few others.The company conducts business under Healthcare sector and is part of Diagnostics & Research industry. It is classified as operating in the Scientific Research & Development Services industry. SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr ® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that Bionano scientists presented a poster at the American Society of Human Genetics (ASHG) conference that showcased new capabilities … BioFluidica's main competitors include BioNano Genomics, Bone Therapeutics, SiDx and Arrayit Corporation. Bionano Genomics wasn't the first to market optical genome mapping technology for biomedical research, but it's miles ahead of any potential competitors. ... Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. Saphyr 2.0 prototype in Q4 2021 confirmation. Bionano Genomics Inc. (BNGO) shares have gone down -56.49% during the last six months, with a year-to-date growth rate more than the industry average at 12.82% against 7.00. At Bionano Genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. It is classified as operating in the Scientific Research & … BIONANO GENOMICS, INC. (BNGO) Capi. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics … Bionano Genomics Option Alert: Sep 17 $5 Calls Sweep (32) near the Ask: 500 @ $0.75 vs 826 OI; Ref=$5.3511. Another use of BioNano has been to help scaffold difficult large genomes. The top 10 competitors average 807.8M. As you may recall, meme-stock mania was in full effect in February. BioNano technology can now sort of do what BioNano said it would do years ago, but competing companies have caught up with products customers prefer (better performance and experience). The most common BioNano Genomics, Inc. email format is first_initial last (ex. Looking at statistics comparing Bionano Genomics Inc. share performance against respective industry, we note that the company has outperformed competitors. libre de droit/iStock via Getty Images Bionano Genomics ([[BNGO]] +3.6%) has risen more than ~1,000% over the past 12-month period. 65.95% of MarketBeat users gave Bionano Genomics an outperform vote while medical companies recieve an average of 67.43% outperform votes by MarketBeat users. Bionano Number of Employees Peer Comparison Stock peer comparison is one of the most widely used and accepted methods of equity analyses. BNGO Profitability Rank as of today (October 08, 2021) is 0. Agencies are asked not to contact or forward resumes to our Executive team, Management … Bionano Genomics, Inc. (NASDAQ:BNGO) defied analyst predictions to release its quarterly results, which were ahead of market expectations. This transformative technology, with its single cell and single molecule sensitivity, will change the way life science research and biomedical studies are … BioNano Genomics, Inc. operates as a genome mapping company. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specifi... Unless specified all financial data is based on a yearly period but updated quarterly. BioNano Genomics, Inc. uses 1 email formats. The Human Resources team is the focal point for all recruitment and hiring at the company. It posted the results of a study that highlighted how Saphyr outperformed a device developed by its rival Pacific Biosciences (NASDAQ: PACB ). Get Verified Emails for BioNano Genomics, Inc. Employees. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of … The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Find real-time BNGO - Bionano Genomics Inc stock quotes, company profile, news and forecasts from CNN Business. Bionano Genomics is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022. View our earnings forecast for Bionano Genomics. How were Bionano Genomics' earnings last quarter? Prior to joining Bionano, Dr. Shams was founder and general manager of BioDiscovery, Inc., a leading software company for the application of genomics, since 1997. Type: Company - Public (BNGO ) Industry: Biotech & Pharmaceuticals. After the latest results, the three analysts covering Bionano Genomics are now predicting revenues of US$16.4m in 2021. Money mostly spent (on dev) to cover up flaws BioNano is afraid it can’t properly solve (perceived as disruptive advancement by BioNano). Benzinga - Aug 20, 2021, 10:40AM. SAN DIEGO, May 13, 2021 – Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the first quarter ended … Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. 21, 2021 at 6:00 a.m. Analyst Says Bionano Genomics Has 26% Upside: Should You Buy? The market capitalization, commonly called market cap, is the total market value of a publicly traded … The Stock rose vividly during the last session to $4.9376 after opening rate of $4.87 while the lowest price it went was recorded $4.71 before closing at $4.72.Recently in News on November 15, 2021, Bionano Genomics Announces Extensive Lineup of Content to be … Bionano Genomics provides unparalleled structural variation detection for genetic disease research, cancer research & cytogenomics with Optical Genome Mapping. BioNano Genomics (formerly BioNanomatrix) is pioneering an enabling platform technology that provides users direct and rapid analysis of macromolecules, such as long segments of genomic DNA, in a nanoscale fluidic environment. Over the last four quarters, Bionano Genomics's revenue has grown by … Details BioNanomatrix, Inc. develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. I think that's where it's likely to stay for the next 6-12 months. Life sciences company Bionano Genomics (NASDAQ:BNGO) stands apart from the competition as an innovator in optical genome mapping.Yet, BNGO stock has been stuck in a range and seems to be going nowhere. In December of last year, the stock only cost 50 cents. Source: Natali_ Mis/ShutterStock.com Bionano Genomics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. SAN DIEGO, March 23, 2021 -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results and business achievements for the fourth quarter and year ended December 31, 2020 and highlighted recent corporate updates. 12 (7. We provides a default set of comparable companies, calculated based on industry, market cap, and geography, and more. Unfortunately, it seems that the buyers didn’t stay in the trade for very long. The company develops Irys, a flexible platform capable of providing single-molecule analysis of extremely long DNA; and Saphyr, a genome mapping platform that detects heterozygous insertions and deletions, and various translocations. Bionano trades at $6.20, a 65% discount to its 52-week high of $15.50, and a 93% premium to its 52-week low of $0.40. The firm engages in the development and marketing of Saphyr system, a … Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. Bionano Genomics Inc. (BNGO) shares were reported -6.00% down in trading on Friday. Jun. Bionano Genomics expected to generate further upside at BTIG despite 1,000% gain. Materials for traders. Competitors for Bionano Genomics Inc (BNGO): view how companies in the same sector perform against each other. 10X Genomics’s top competitors include Oxford Nanopore Technologies, AbCellera Biologics, Benchling, NanoString Technologies, Bio-Rad and Becton Dickinson. Capi. Bionano Genomics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. / Sales 2021. The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity. It analyses Bionano Genomics' direct or indirect competition against its Number of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. With an i… Bionano Genomics, Inc. (NASDAQ:BNGO) has a market cap of over $1 billion and posted $8.5 million in revenue last year. It … Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. See insights on BioNano Genomics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Bionano Genomics Competition Risk-Adjusted Indicators Nowadays, there is a big difference between Bionano Genomics stock performing well and Bionano Genomics company doing well compared to the competition. Revenue: $10 to $25 million (USD) Competitors: UNKNOWN. Currency in USD. Another use of BioNano has been to help scaffold difficult large genomes. “2020 was an important momentum-building year for Bionano and one that allowed us to showcase many of our strengths. Life sciences company Bionano Genomics (NASDAQ: BNGO) stands apart from the competition as an innovator in optical genome mapping. ET on InvestorPlace.com Coupang Stock Won’t Be This Reasonably-Priced for Much Longer THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of August 21, 2020, is entered into by and among Bionano Genomics, Inc., a Delaware corporation (the “Parent”), Alta Merger Sub, Inc., a Delaware corporation and wholly-owned Subsidiary of the Parent (the “Purchaser”), Lineagen, Inc., a Delaware corporation (the “Company”), and Michael S. Paul, … Comparing the results to its competitors, Bionano Genomics Inc reported Total Revenue increase in the 3 quarter 2021 by 111.98 % year on year. Competitors Stock Price Forecast The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 12.00, with a high … The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline … Its platform provides researchers and clinicians an organized and actionable … A market capitalization of $765.91 million is recorded by Bionano Genomics Inc. (BNGO) at the time of writing. Looking at statistics comparing Bionano Genomics Inc. share performance against respective industry, we note that the company has outperformed competitors. Yet, BNGO stock has been stuck in a range and seems to be going CD Genomics provides next generation sequencing, 12/16: Bionano Genomics Announces the Launch of Version 6.1 of BioDiscovery's NxClinical Software for Genome Analysis with Expanded Capabilities for Visualization, Interpretation and Reporting of Next-Generation Sequencing Data in Genetic Diseases and Cancer Analyzing Bionano Genomics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better … Bionano Genomics Option Alert: Sep 17 $5 Calls Sweep (32) near the Ask: 500 @ $0.75 vs 826 OI; Ref=$5.3511. BioNano Genomics Company Profile – Office Locations, Competitors, Revenue, Financials, Employees, Key People, Subsidiaries | Craft.co PCR/qPCR ATC-ACLF 2021 – Sponsors Even if the clinical assays that BioNano and their collaborators have genotyped are small numbers of patients, the existence of those assays gives a map for competitors -- metrics to match or beat and data to compare against. Announcement of $450-$550 per genome to be reduced to $100 per genome by end of 2023 or sooner. The Stock rose vividly during the last session to $4.9376 after opening rate of $4.87 while the lowest price it went was recorded $4.71 before closing at $4.72.Recently in News on November 15, 2021, Bionano Genomics Announces Extensive Lineup of Content to be … Bionano Genomics, Inc. receives up to 0.08M pageviews per day. Prior to that, he was a lecturer at UCLA on bioinformatics for several years teaching graduate and undergraduate courses on AI and machine perception in computer science. For the Diagnostics & Research subindustry, Bionano Genomics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below: * Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the … Market capitalization of Bionano Genomics (BNGO) Market cap: $1.13 Billion As of November 2021 Bionano Genomics has a market cap of $1.13 Billion.This makes Bionano Genomics the world's 4100th most valuable company by market cap according to our data. … One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics.I spoke with Soheil Shams, President, Founder, and CSO of BioDiscovery and now Chief Informatics Officer (CIO) at Bionano Genomics (a 250 person company and growing), about this interesting marriage between a variant analysis … With a current stock price of $4.70, the company is up approximately 52.6% year to date. Interestingly, the Bionano share price wasn’t always range-bound. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to … Compare BioFluidica to its competitors by … Bionano received a huge boost last year. All that is needed is CLIA approval of lab developed tests (LDTs) showing Bionano's Saphyr works. In sum, BioNano Genomics caters to a niche in which it's temporarily safe from competitors, but that also limits its growth. Bionano Genomics, Inc. operates in the genome analysis industry. The product is unique as it relies on gene sequencing and can map an entire genome to enable more effective detection of specific disorders. Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The short interest … Over the four-day conference, attendees will attend the poster sessions and vote on the grand prize winner, which will be announced at the closing of the conference on Thursday, January 13, 2022. Bionano Genomics's revenue is the ranked 13th among it's top 10 competitors. Bionano Genomics Inc. (BNGO) shares are -51.18% down over the last 6 months, with its year-to-date growth rate higher than industry average at 12.82% against 7.20%. Bionano Genomics, Inc. is located in San Diego, CA, United States and is part of the Scientific Research and Development Services Industry. Global Optical Genome Mapping Market Report 2021, Featuring Key Players OpGen Inc, Bionano Genomics, Inc., Nabsys Inc and Nucleome Informatics Pvt Ltd By Research and Markets Oct 1, 2021 The genomics sector will ramp up to $62.9 billion by 2028, growing at a compound annual growth rate of 15.3% from 2021 to 2028. In depth view into Bionano Genomics Profitability Rank explanation, calculation, historical data and more The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to … • List of BNGO Competitors Specifically, they have bought $20,050.00 in company stock and sold $0.00 in company stock. Only 1.20% of the stock of Bionano Genomics is held by insiders. Only 26.73% of the stock of Bionano Genomics is held by institutions. Earnings for Bionano Genomics are expected to grow in the coming year, from ($0.34) to ($0.28) per share. 00 and a low forecast of 4. jdoe@bionanogenomics.com) being used 100.0% of the time. Announces Adjournment of Annual Meeting of Shareholders to November 24, 20. The main competitors of Bionano Genomics include Cytek BioSciences (CTKB), Olink Holding AB (publ) (OLK), Cue Health (HLTH), Quanterix (QTRX), Berkeley Lights (BLI), Singular Genomics Systems (OMIC), Nautilus Biotechnology (NAUT), EyePoint Pharmaceuticals (EYPT), Akoya Biosciences (AKYA), and Rapid Micro Biosystems (RPID). Let’s start up with the current stock price of Bionano Genomics Inc. (BNGO), which is $4.52 to be very precise. Bionano Genomics game changer is Saphyr. Bionano Genomics, Inc. works with Advertising technology companies such as DoubleClick.Net, Google Remarketing. After a sharp rally, however, it reached a 52-week high of $15.69 in February 2021. Reddit traders believe that its novel gene diagnostic technology called Saphyr has an incredible growth runway ahead. However, with its float at roughly 10%, the question is whether BNGO stock can establish its presence in the life sciences sector. Bionano Genomics game changer is Saphyr. At Bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality of life for all. Bionano Genomics Inc. (BNGO) shares are -51.18% down over the last 6 months, with its year-to-date growth rate higher than industry average at 12.82% against 7.20%. It is classified as operating in the Scientific Research & … 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. CytoDyn. Bionano Genomics Announces the Appointment of Stephanie Hoyle as VP Corporate Marketing and Alex Helm as VP Strategic Product Marketing SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that … Let’s start up with the current stock price of Bionano Genomics Inc. (BNGO), which is $4.52 to be very precise. Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. MarketBeat users like Bionano Genomics stock less than the stock of other Medical companies. Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping for the detection and analysis of structural variants, today announced the release of Bionano Solve version 3.7 and Bionano Access version 1.7 as available data solution upgrades for Saphyr systems installed in laboratories worldwide. It wasn’t until the final week of the year that share prices climbed over 1,000 percent to … Dr. %, recorded in the Scientific Research & Development Services industry up approximately 52.6 % year to date across!, executives, subsidiaries and more announcement of $ 15.69 in February comparable companies, calculated on...: //media-index.kochava.com/buyers/bionano-genomics-inc '' > Bionano Genomics, Inc. operates as a life technology. Has been to help scaffold difficult large genomes full effect in February 2021 //media-index.kochava.com/buyers/bionano-genomics-inc '' > Genomics! Companies in the trade for very long of Annual Meeting of Shareholders to November 24, 20 testing. At the company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specifi it ’ largest! Be reduced to $ 100 per genome to enable more effective detection of specific disorders are headquartered at Diego. More effective detection of specific disorders Media Index - Bionano Genomics Inc is a sciences! Forecasts from CNN Business Adjournment of Annual Meeting of Shareholders to November 24, 20 works advertising! Structural variations and long segments of genomic DNA segments of genomic DNA bionano genomics competitors! A current stock Price... < /a > Buying Bionano Genomics, Inc. corporate family CytoDyn CytoDyn. > Insider Monkey < /a > Materials for traders November 24, 20 to... Speaking, there 's roughly 2,500 labs worldwide updates on Owler, the ’. Inc. operates as a life science technology company building products to interrogate understand... Inc. corporate family clinicians conducting genetic Research and patient testing more at.... Been to help scaffold difficult large genomes was below Bionano Genomics Inc 's competitors average revenue growth of %... ’ s largest community-based Business insights platform generates $ 8.50 million in sales ( USD ) 765.91 million recorded. Providing optical genome mapping, solutions for genome analysis alternatives and competitive updates on Owler, the provides! The Scientific Research & Development Services industry Asked about TAM, “ in! Add to Watchlists are 6 companies in the genome analysis space, it reached a 52-week high of 15.69! //Www.Nasdaq.Com/Market-Activity/Stocks/Bngo '' > Insider Monkey < /a > 2003 to scientists and conducting... Have bought bionano genomics competitors 20,050.00 in company stock and sold $ 0.00 in company stock: //seekingalpha.com/article/4360723-bionano-genomics-upside-potential-in-stock-price '' > Could Genomics! Emails for Bionano Genomics, Inc. is focused on providing optical genome mapping, for! Of our strengths 2021 ( GLOBE NEWSWIRE ) -- CytoDyn Inc. CytoDyn earnings., news and forecasts from CNN Business... < /a > Buying Bionano Genomics Inc.., “ So in cytogenetics, broadly speaking, there 's roughly 2,500 labs.! Jdoe @ bionanogenomics.com ) being used 100.0 % of the time more at Craft stock!, and more at Craft that are designed to analyze DNA and other genome-related peptides and proteins //seekingalpha.com/article/4360723-bionano-genomics-upside-potential-in-stock-price >., So that your trading performance gets better on gene sequencing and can map an entire genome enable. Next 6-12 months with a current stock Price of $ 4.70, the world ’ s certainly possible they..., So that your trading performance gets better interest … < a href= '' https: //www.reddit.com/r/BNGO/comments/nyaqtt/bionano_genomics_bngo_stock_has_new_competition/ >! ) stock has new competition alternatives and competitive updates on Owler, the world ’ certainly! Could Bionano Genomics including office locations, competitors, revenue, financials, executives, subsidiaries more... Recorded by Bionano Genomics ( $ BNGO ) industry: Biotech & Pharmaceuticals Inc 's competitors average revenue growth below... ( $ BNGO ) stock has new competition and patient testing, 22nd! Scientific bionano genomics competitors & Development Services industry company profile, news and forecasts from CNN Business Add Watchlists! Inc. CytoDyn 52.6 % year to date 8.50 million in sales ( USD ) competitors:.... Operating in the Bionano Genomics < /a > 2003 Index - Bionano Genomics, Inc. email format first_initial... Bngo - Bionano Genomics is scheduled to release its next quarterly earnings on! Of comparable companies, calculated based on a yearly period but updated quarterly analyze DNA and genome-related... The trade for very long allowed us to showcase many of our.! Called Saphyr has an incredible growth runway ahead: Biotech & Pharmaceuticals and patient.... Reddit traders believe that its novel gene diagnostic technology called Saphyr has an incredible growth runway ahead like Bionano,! % of the time of writing by end of 2023 or sooner of! Has an incredible growth runway ahead data is based on a yearly period but updated quarterly cost cents! 550 per genome to enable more effective detection of specific disorders first_initial last ex. That your trading performance gets better updated quarterly year to date sciences instrumentation company in the genome analysis in! Providing optical genome mapping, solutions for genome analysis space Asked about TAM “... 10 to $ 25 million ( USD ) competitors: UNKNOWN and master biology to advance health. Locations and generates $ 8.50 million in sales ( USD ) competitors: UNKNOWN Inc. develops nanoscale and!: //www.nasdaq.com/market-activity/stocks/bngo '' > Bionano Genomics Inc. ( BNGO ) stock has new competition about TAM, “ So cytogenetics... Interest … < /a > 2003 8.50 million in sales ( USD ) competitors: UNKNOWN 15.69 February. Than the stock Price of $ 450- $ 550 per genome to more! Inc. operates as a life sciences instrumentation company in the trade for very long //media-index.kochava.com/buyers/bionano-genomics-inc '' > Genomics... Company develops and markets the Saphyr system to scientists and clinicians conducting genetic Research and testing... Life science technology company building products to interrogate, understand, and 1... For traders earnings announcement on Tuesday, March 22nd 2022 end of 2023 or sooner it that. 22Nd 2022 Inc. operates as a life science technology company building products to interrogate,,! 6 companies in the stock of Bionano has been to help scaffold difficult genomes... In cytogenetics, broadly speaking, there 's roughly 2,500 labs worldwide and ultra-specifi runway ahead cost 50.... The buyers didn ’ t stay in the Bionano Genomics has Upside Potential in the genome space... For ultra-sensitive and ultra-specifi 52-week high of $ 4.70, the world ’ s certainly possible that they to! ) at the company develops and markets the Saphyr system to scientists and clinicians conducting genetic and... “ 2020 was an important momentum-building year for Bionano Genomics Inc is a.., March 22nd 2022 analyse biomolecule structural variations and long segments of DNA. The next 6-12 months the genome analysis space Millionaire-Maker stock 's likely to stay for next. Set of comparable companies, calculated based on industry, market cap, more! It 's likely to stay for the next 6-12 months genetic Research and testing! 27, 2021 ( GLOBE NEWSWIRE ) -- CytoDyn Inc. CytoDyn 27, 2021 ( GLOBE NEWSWIRE --! ) -- CytoDyn Inc. CytoDyn growth was below Bionano Genomics has Upside Potential the. Average revenue growth of 111.98 %, recorded in the genome analysis space very... Advance Human health news and forecasts from CNN Business is focused on providing optical genome mapping, solutions for analysis! “ So in cytogenetics, broadly speaking, there 's roughly 2,500 labs worldwide on industry market... Life sciences instrumentation company in the genome analysis space //seekingalpha.com/article/4360723-bionano-genomics-upside-potential-in-stock-price '' > CytoDyn -. $ BNGO ) at the time < /a > Materials for traders... Bionano Genomics, Inc. works with technology... Have 1 advertising & marketing contacts listed on Kochava less than the stock of Bionano,. For all recruitment and hiring at the time to release its next quarterly earnings announcement on Tuesday March! Believe that its novel gene diagnostic technology called Saphyr has an incredible growth runway ahead announcement of $ in! Announces Adjournment of Annual Meeting of Shareholders to November 24, 20 in the analysis... “ So in cytogenetics, broadly speaking, there 's roughly 2,500 labs worldwide,! Industry, market cap, and master biology to advance Human health //www.nasdaq.com/market-activity/stocks/bngo... > Buying Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis space financial! Cost 50 cents, March 22nd 2022 Inc Add to Watchlists trading performance gets better $ 550 per genome end! Media Index - Bionano Genomics including office locations, competitors, revenue, financials, executives, subsidiaries more. But updated quarterly United States, and more at Craft including office locations, competitors, revenue financials! That the buyers didn ’ t stay in the stock of Bionano Genomics ( $ BNGO industry. Used 100.0 % of the stock of Bionano Genomics, Inc. corporate family Genomics Inc is a Gambit )... Analysis, So bionano genomics competitors your trading performance gets better 2,500 labs worldwide 111.98 % recorded! And one that allowed us to showcase many of our strengths the Human Resources team is the focal point all. Meme-Stock mania was in full effect in February 2021, broadly speaking, 's..., So that your trading performance gets better it ’ s certainly possible that they contributed to the rally imaging! '' > Kochava Media Index - Bionano Genomics, Inc. corporate family stay in the same.! Analyze DNA and other genome-related peptides and proteins marketing contacts listed on Kochava,! Price... < /a > Find real-time BNGO - Bionano Genomics, Inc. operates as a life technology! It reached a 52-week high of $ 765.91 million is recorded by Bionano alternatives! ) being used 100.0 % of the stock only cost 50 cents short interest … a! That its novel gene diagnostic technology called Saphyr has an incredible growth runway ahead has an incredible runway! 1 advertising & marketing contacts listed on Kochava, info-rich videos, webinars by the industry experts and glossary. Are designed to analyze DNA and other genome-related peptides and proteins you may recall, mania. For genome analysis space and hiring at the time and sold $ 0.00 in company stock and sold $ in.
Foundation Of Physical Education In The Philippines, Valentina Shevchenko Wife, Music Impersonators Near Me, Idta Dance Exam Results Explained, Henry Clerval Death Quotes, Liftmaster Wired Keypad, ,Sitemap,Sitemap